The objectives of the present work were two-fold: 1 – to study, and compare, the relative expression of PPARγ in the normal gland and in benign and malignant diseases of the thyroid; and 2 – to correlate PPARγ immunostaining with clinical and pathological characteristics of patients with thyroid carcinomas of follicular origin. Here, PPARG is linked to thyroid gland carcinoma.